Emily P. Neely, MD

NPI 1598812455ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Nashville, TN

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Nashville, Tennessee, trained at University of Mississippi School of Medicine (class of 2006). Their prescriptions cost Medicare Part D more than their services did: $1,580,771 for 3,061 claims, against $98,429 paid for services in 2024. Novo Nordisk Inc was the largest of 26 companies reporting payments in 2025, $3,089 in all, mostly food and beverage.

Overview

NPI	1598812455
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jan 4, 2007
Last updated in NPPES	Nov 22, 2019

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	47619	TN

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (TN)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	285
Services billed	3,368 across 18 procedure codes
Paid by Medicare	$98,429

Part D prescriptions in 2024

Prescriptions (claims)	3,061 · 6,969 30-day fills
Patients	380
Total drug cost	$1,580,771
Generic share	35% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Mississippi School of Medicine
Graduation year	2006
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth